NORML

AUGUST 26, 2019

These were moms and dads and grandparents of children [with intractable epilepsy] who were using medical cannabis oils. As in, no to anyone who wasn’t an epilepsy patient.]. ” and “We only want to see data from an American source.” There are some minimum and maximum cannabinoid contents with the program.

Marijuana 251

Marijuana Legalization Programs Oil 251

Cannabis Cheri

APRIL 1, 2022

In fact, a lot of people don’t realize that the keto diet was originally designed to treat seizures in children suffering from treatment resistant epilepsy. We know that cannabinoids like THC and CBD are fat soluable. Cannabinoids and their metabolites are stored primarily in fat cells. Read more here.

Edibles 203

Edibles Cannabis Cannabinoids Oil 203

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. Dr. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

The Cannigma

OCTOBER 21, 2021

More than likely, the effects of cannabinoids like CBD and THC are altered during the ketogenic diet, but unfortunately there has been very little research on this topic. This would hypothetically correlate with the altered effects of cannabinoids like THC and CBD, but the study did not look at that. As per usual, more data is needed.

Cannabinoids 144

Cannabinoids Edibles Conditions Data 144

Otherside Farms

JANUARY 24, 2019

Federal regulators have approved two clinical studies testing whether a marijuana-based epilepsy drug may help prevent seizures among epileptic children. During the past couple of decades, investigators have discovered two different types of cannabinoid receptors in the brain, spinal cord, and peripheral tissues, including immune tissues.

Clinical Trials 45

Clinical Trials Epilepsy Marijuana Pharmaceutical 45

Cannabis Law Report

AUGUST 10, 2021

Commenting on the MHRA approval of GW’s cannabidiol, Tuberous Sclerosis Association (TSA) Chief Executive Louise Fish said: “One in every two people living with TSC-related epileptic seizures has difficult to treat epilepsy that does not respond to traditional anti-epileptic drugs. TSC is typically diagnosed in childhood. (5)

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Consumers spent roughly $31.3 increase in annual sales. 2 The seeds of C.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

SEPTEMBER 12, 2021

Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. But do medical cannabinoids actually help animal patients? She sought to make sense of the issues during her presentation “Medical Cannabinoids Revisited” at AVMA Virtual Convention 2021 on Aug.

Patients 105

Patients Pets Seed-To-Sale Cannabinoids 105

The Cannigma

NOVEMBER 1, 2023

Despite being touted as a wonder drug, CBD doesn’t work for everyone, and many clinicians are now leaning into other cannabinoids. And along with research, real-world data can help us understand how topical products infused with minor cannabinoids could help with various aches and pains. 1 2 So why put CBDA in a body lotion?

Topical 86

Topical Data Cannabinoids Terpenes 86

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52

Safety Cannabinoids Events Data 52

The Cannigma

JUNE 29, 2021

Chemotypes : Types of cannabis that are grouped by their most abundant cannabinoid. Chemovars: Types of cannabis which are loosely defined and grouped, based on at least one or two of the most abundant cannabinoids and two-to-four main terpenes. 10% THC and 30% THC plants could both be Type I, as long as THC is the major cannabinoid).

Terpenes 138

Terpenes Research and Development Cannabinoids Concentrates 138

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

The two active cannabinoids in marijuana are cannabidiol (CBD) and tetrahydrocannabinol (THC), the latter of which causes psychoactive effects while the former does not. This system naturally produces cannabinoids in the bloodstream, but chronic stress, anxiety, and other stimuli can stifle the production of natural endocannabinoids.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

The Cannigma

JULY 17, 2022

You don’t need a medical condition or a paid subscription – the ROC serves curious consumers, medical professionals, and anyone else who is looking to better their life through cannabinoid therapies. The advice and suggestions are based on data, including the results from ROC’s own cannabis research registry.

Advocacy 125

Advocacy Education Events Epilepsy 125

Sensi Seeds

DECEMBER 10, 2018

For the time being, and thanks to the onset of a new era of cannabis legalization, thousands of studies on cannabis and cannabinoids are published each year by the scientific community. Today, there is an enormous quantity and varied quality of scientific data, and this study is a fundamental tool that optimizes the way we access it.

Medicine 81

Medicine Research and Development Data Policy 81

Veriheal

APRIL 11, 2022

We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds. We could potentially develop north of 11,000 drugs that are cannabinoid-based. This means that U.S.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Cannabis Law Report

JANUARY 10, 2022

Minor Cannabinoids Market Size, Share & Trends Analysis Report by Product (CBG, CBC, CBN, THCV, CBGA), by Application (Pain Management, Neurological Disorders), and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering. minor cannabinoids market size is expected to reach USD 26.2

Cannabinoids 40

Cannabinoids Clinical Trials Research and Development Supply Chain 40

Cannabis Law Report

DECEMBER 1, 2019

A young girl with a drug-resistant form of epilepsy is believed to be the first and only patient in Singapore who has been given approval to use cannabis-derived medication. The move follows approvals by lawmakers in the United States to use the medication to treat rare kinds of childhood epilepsy in that country.

Epilepsy 45

Epilepsy Cannabinoids Therapy Treatment 45

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 40

Pharmaceutical Data CBD Clinical Trials 40

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Green Relief

JANUARY 18, 2018

Due to its non-psychoactive healing properties, Cannabidiol (CBD) has become a very popular option for patients seeking a natural alternative to treat conditions such as chronic pain, anxiety, epilepsy, and more. UNDERSTANDING THE BENEFITS OF DIFFERENT CANNABINOIDS. 3%), resulting in very minimal psychoactive stimulation.

CBD 56

CBD Cannabinoids Chronic Pain Epilepsy 56

LifeCannMD

JANUARY 2, 2025

Clinical Applications Pain Management A systematic review by Whiting analyzed 79 trials and found moderate-quality evidence supporting the use of cannabinoids for chronic pain. A comprehensive review published in JAMA Oncology examined clinical data and case reports on cannabis as an anticancer agent.

Oil 98

Oil Concentrates Treatment Chronic Pain 98

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. Apart from business leaders, many corporate and government institutions are funding the research and development of cannabinoids for medical applications,” reads an excerpt from the report. Alzheimer’s.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Leaf Science

JULY 23, 2019

In spite of this, research has shown that THC as much as the other cannabinoids present in cannabis has medicinal value to humans. In the UK, cannabis was legalized for medicinal purposes in 2018 which saw patients of epilepsy and multiple sclerosis able to access pharmaceutical cannabis derivatives such as Sativex and Epidiolex.

Strains 74

Strains Epilepsy Cannabinoids THC 74

TheAnswerPage

JULY 19, 2022

Have researchers found that patients who use cannabidiol (CBD)-rich extract therapy for the treatment of epilepsy require a lower dose of CBD medication as compared to those who use purified CBD therapy for the treatment of epilepsy? Pamplona F, da Silva L and Coan A. 12 September 2018. Sec.Neuropharmacology. See the Answer.

Epilepsy 40

Epilepsy Therapy Extraction Data 40

The Joint Blog

JANUARY 23, 2020

. “Medicinal cannabis has been reported to have potential efficacy in reducing pain, muscle spasticity, chemotherapy-induced nausea and vomiting, and intractable childhood epilepsy. One isolated study indicates some potential efficacy for an oral cannabinoid /terpene combination in ADHD.

Clinical Trials 52

Clinical Trials Marijuana Sleep Cannabinoids 52

The Cannigma

SEPTEMBER 13, 2021

Also in 2020, Israel surpassed Germany as the world’s largest importer of medical cannabis flower, according to data from Israel’s online Cannabis Magazine. Most notably, scientist Raphael Mechoualm of Hebrew University of Jeruslaem, is credited with isolating tetrahydrocannabinol (THC), as well the cannabinoid 2-AG and anandamide.

Legalization 100

Legalization Decriminalization Patients Cannabis 100

LifeCannMD

JANUARY 2, 2024

Some animal-based studies go as far as to suggest cannabinoids might slow cancer cell growth. Florida Epilepsy Patients : CBD blocks the ability of LPI to amplify nerve signals in a brain region and has been known to reduce the frequency and severity of seizures in epilepsy.

Conditions 52

Conditions Nerve Pain Marijuana Epilepsy 52

CannaTech

SEPTEMBER 16, 2018

But this gap restricts patient access to a medicine that can offer relief to a long list of conditions including chronic pain, seizures attributed to epilepsy, as well as mood disorders such as anxiety and depression. This knowledge gap isn’t surprising, as cannabis as a medicine is non-traditional in its very nature.

Education 66

Education Medicine Clinical Trials Patients 66

Otherside Farms

FEBRUARY 14, 2019

billion by 2020; the World Anti-Doping Agency eliminated the CBD from its list of banned substances; The Food and Drug Administration (FDA) for the first time approved a drug for epilepsy that contained CBD oil, prompting the US Drug Enforcement Administration to change its position about the CBD. What is CBD? Is CBD Legal?

CBD 65

CBD Legalization Hemp Chronic Pain 65

Puff Puff Post

JANUARY 1, 2020

Cannabinoids even alleviate certain types of pain that opiates don’t always treat well. Furthermore, cannabinoids treat these symptoms as the doctors either do chemotherapy or prescribe antivirals for the HIV. Approved Cannabinoid-Based Medications. They take prescription cannabinoids in pill or liquid form.

Treatment 49

Treatment Clinical Trials Research and Development Cannabinoids 49

The Joint Blog

MARCH 16, 2020

For the study researchers examined the use of marijuana over a 12-month period in a cohort of patients with chronic diseases, such as HIV, epilepsy, and fibromyalgia. We recruited patients with various chronic diseases who use cannabis and collected data regarding patterns of cannabis use as well as mental health, personality and QoL.

Patients 49

Patients Marijuana Epilepsy Treatment 49

Ellementa

NOVEMBER 4, 2019

CBD research shows it can be effective in treating severe forms of epilepsy such as Dravet syndrome and Lennox-Gastaut syndrome (LGS). ” According to cannabinoid researcher, Dr. Ethan Russo, there’s a better term to use when describing CBD. CBD as an anti-seizure medication is affecting the mind.

CBD 14

CBD Tincture Blood Pressure THC 14

Canna Care Docs

DECEMBER 16, 2020

Among the 100-plus chemicals called cannabinoids in the cannabis plant, the two that are best known for their medicinal benefits are tetrahydrocannabinol (THC) and cannabidiol (CBD). Research is ongoing, but the existing data and anecdotal reports show potential. What is medical marijuana?

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Cannabis Law Report

APRIL 4, 2019

Further there is a growing body of evidence that various forms of cannabis could help in the treatment of epilepsy and seizures, post-traumatic stress disorder (PTSD), glaucoma, dementia, Alzheimers, autism, fibromyalgia and a range of auto-immune diseases.

Cultivation 40

Cultivation Research and Development Chronic Pain Data 40

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020.

Pharmaceutical 51

Pharmaceutical Clinical Trials Research and Development Programs 51

Green Relief

JANUARY 18, 2018

Due to its non-psychoactive healing properties, Cannabidiol (CBD) has become a very popular option for patients seeking a natural alternative to treat conditions such as chronic pain, anxiety, epilepsy, and more. UNDERSTANDING THE BENEFITS OF DIFFERENT CANNABINOIDS. 3%), resulting in very minimal psychoactive stimulation.

Cannabinoids 40

Cannabinoids Chronic Pain CBD Conditions 40

Puff Puff Post

DECEMBER 28, 2018

An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. Cannabinoids could be a relatively safe and inexpensive alternative to anti-psychotics and other pharmaceutical drugs if we see more studies come forth with supporting evidence. An Alternative to Other Drugs.

Treatment 76

Treatment Oil CBD Therapy 76